Clinical Decision Support Systems in Breast Cancer: A Systematic Review

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2020 Feb 12

PMID 32041094

Citations 31

Authors

Claudia Mazo

Cathriona Kearns

Catherine Mooney

William M Gallagher

Affiliations

Soon will be listed here.

Abstract

Breast cancer is the most frequently diagnosed cancer in women, with more than 2.1 million new diagnoses worldwide every year. Personalised treatment is critical to optimising outcomes for patients with breast cancer. A major advance in medical practice is the incorporation of Clinical Decision Support Systems (CDSSs) to assist and support healthcare staff in clinical decision-making, thus improving the quality of decisions and overall patient care whilst minimising costs. The usage and availability of CDSSs in breast cancer care in healthcare settings is increasing. However, there may be differences in how particular CDSSs are developed, the information they include, the decisions they recommend, and how they are used in practice. This systematic review examines various CDSSs to determine their availability, intended use, medical characteristics, and expected outputs concerning breast cancer therapeutic decisions, an area that is known to have varying degrees of subjectivity in clinical practice. Utilising the methodology of Kitchenham and Charter, a systematic search of the literature was performed in Springer, Science Direct, Google Scholar, PubMed, ACM, IEEE, and Scopus. An overview of CDSS which supports decision-making in breast cancer treatment is provided along with a critical appraisal of their benefits, limitations, and opportunities for improvement.

Citing Articles

AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosis.

Alum E Discov Oncol. 2025; 16(1):313.

PMID: 40082367 PMC: 11906928. DOI: 10.1007/s12672-025-02064-7.

Externally validated and clinically useful machine learning algorithms to support patient-related decision-making in oncology: a scoping review.

Santos C, Amorim-Lopes M BMC Med Res Methodol. 2025; 25(1):45.

PMID: 39984835 PMC: 11843972. DOI: 10.1186/s12874-025-02463-y.

A Review on Integrating Breast Cancer Clinical Data: A Unified Platform Perspective.

Kumar R, Joghee S Curr Treat Options Oncol. 2025; 26(1):1-13.

PMID: 39752094 DOI: 10.1007/s11864-024-01285-2.

Prediction of breast cancer Invasive Disease Events using transfer learning on clinical data as image-form.

Fanizzi A, Bove S, Comes M, Di Benedetto E, Latorre A, Giotta F PLoS One. 2024; 19(11):e0312036.

PMID: 39570983 PMC: 11581389. DOI: 10.1371/journal.pone.0312036.

Clinical decision making in prostate cancer care-evaluation of EAU-guidelines use and novel decision support software.

Engesser C, Henkel M, Alargkof V, Fassbind S, Studer J, Engesser J Sci Rep. 2024; 14(1):19113.

PMID: 39155288 PMC: 11330959. DOI: 10.1038/s41598-024-70292-y.

References

Nelson K, Mahant S . Shared decision-making about assistive technology for the child with severe neurologic impairment. Pediatr Clin North Am. 2014; 61(4):641-52. DOI: 10.1016/j.pcl.2014.04.001. View

Piccart-Gebhart M, Sotiriou C . Adjuvant chemotherapy--yes or no? Prognostic markers in early breast cancer. Ann Oncol. 2008; 18 Suppl 12:xii2-7. DOI: 10.1093/annonc/mdm532. View

Entwistle V, Carter S, Cribb A, McCaffery K . Supporting patient autonomy: the importance of clinician-patient relationships. J Gen Intern Med. 2010; 25(7):741-5. PMC: 2881979. DOI: 10.1007/s11606-010-1292-2. View

Konstantinidis S, Bamidis P . Why decision support systems are important for medical education. Healthc Technol Lett. 2016; 3(1):56-60. PMC: 4814870. DOI: 10.1049/htl.2015.0057. View

Ravdin P, Siminoff L, Davis G, Mercer M, Hewlett J, Gerson N . Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001; 19(4):980-91. DOI: 10.1200/JCO.2001.19.4.980. View

Regan M, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L . Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up. Lancet Oncol. 2011; 12(12):1101-8. PMC: 3235950. DOI: 10.1016/S1470-2045(11)70270-4. View

Schaarup C, Pape-Haugaard L, Hejlesen O . Models Used in Clinical Decision Support Systems Supporting Healthcare Professionals Treating Chronic Wounds: Systematic Literature Review. JMIR Diabetes. 2018; 3(2):e11. PMC: 6238865. DOI: 10.2196/diabetes.8316. View

Anders C, Hsu D, Broadwater G, Acharya C, Foekens J, Zhang Y . Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008; 26(20):3324-30. DOI: 10.1200/JCO.2007.14.2471. View

Wishart G, Azzato E, Greenberg D, Rashbass J, Kearins O, Lawrence G . PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res. 2010; 12(1):R1. PMC: 2880419. DOI: 10.1186/bcr2464. View

10.

Njie G, Proia K, Thota A, Finnie R, Hopkins D, Banks S . Clinical Decision Support Systems and Prevention: A Community Guide Cardiovascular Disease Systematic Review. Am J Prev Med. 2015; 49(5):784-795. PMC: 5074080. DOI: 10.1016/j.amepre.2015.04.006. View

11.

Kaushal R, Kern L, Barron Y, Quaresimo J, Abramson E . Electronic prescribing improves medication safety in community-based office practices. J Gen Intern Med. 2010; 25(6):530-6. PMC: 2869410. DOI: 10.1007/s11606-009-1238-8. View

12.

Seroussi B, Bouaud J . Using OncoDoc as a computer-based eligibility screening system to improve accrual onto breast cancer clinical trials. Artif Intell Med. 2003; 29(1-2):153-67. DOI: 10.1016/s0933-3657(03)00040-x. View

13.

Hemens B, Holbrook A, Tonkin M, Mackay J, Weise-Kelly L, Navarro T . Computerized clinical decision support systems for drug prescribing and management: a decision-maker-researcher partnership systematic review. Implement Sci. 2011; 6:89. PMC: 3179735. DOI: 10.1186/1748-5908-6-89. View

14.

Holbrook A, Xu S, Banting J . What factors determine the success of clinical decision support systems?. AMIA Annu Symp Proc. 2004; :862. PMC: 1480133. View

15.

Legare F, Robitaille H, Gane C, Hebert J, Labrecque M, Rousseau F . Improving Decision Making about Genetic Testing in the Clinic: An Overview of Effective Knowledge Translation Interventions. PLoS One. 2016; 11(3):e0150123. PMC: 4777394. DOI: 10.1371/journal.pone.0150123. View

16.

Aaltomaa S, Lipponen P, Eskelinen M, Kosma V, Marin S, Alhava E . Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol. 1992; 118(1):75-81. DOI: 10.1007/BF01192316. View

17.

Azim Jr H, Partridge A . Biology of breast cancer in young women. Breast Cancer Res. 2014; 16(4):427. PMC: 4303229. DOI: 10.1186/s13058-014-0427-5. View

18.

Zheng K, Padman R, Johnson M, Diamond H . Understanding technology adoption in clinical care: clinician adoption behavior of a point-of-care reminder system. Int J Med Inform. 2005; 74(7-8):535-43. DOI: 10.1016/j.ijmedinf.2005.03.007. View

19.

Dowsett M, Sestak I, Regan M, Dodson A, Viale G, Thurlimann B . Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5. J Clin Oncol. 2018; 36(19):1941-1948. PMC: 6049399. DOI: 10.1200/JCO.2017.76.4258. View

20.

Nurek M, Kostopoulou O, Delaney B, Esmail A . Reducing diagnostic errors in primary care. A systematic meta-review of computerized diagnostic decision support systems by the LINNEAUS collaboration on patient safety in primary care. Eur J Gen Pract. 2015; 21 Suppl:8-13. PMC: 4828626. DOI: 10.3109/13814788.2015.1043123. View